| Title: | Integrated intraocular-plasma proteomics reveals conserved biomarkers for diabetic retinopathy progression: a multi-fluid biopsy study |
| Journal: | Diabetologia |
| Published: | 12 Mar 2026 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/41817688/ |
| DOI: | https://doi.org/10.1007/s00125-026-06708-3 |
Publication 17404
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
Aims/hypothesisThe aim of this study was to identify conserved biomarkers for diabetic retinopathy progression, addressing the lack of minimally invasive biomarkers to track the entire continuum of diabetic retinopathy.MethodsWe conducted high-throughput proteomics (SomaScan v4.1) on aqueous humour from the Guangdong DR Multiple-Omics Study (n=32). Temporal protein clusters were identified using soft clustering of temporal trajectories. Candidates were validated in a US dataset and localised via single-cell RNA-seq in an oxygen-induced retinopathy mouse model. The clinical relevance of plasma-detectable markers was assessed cross-sectionally and prospectively in individuals with diabetes from the UK Biobank (n=2495).ResultsIn the discovery dataset (mean age 68.5±9.0 years; 56.3% men, 43.8% women), temporal proteomic profiling identified 40 candidate biomarkers whose concentration showed monotonic changes during diabetic retinopathy progression. Of these, 25 showed conserved directional patterns in the validation dataset (17 increasing and eight decreasing, all p<0.05). Single-cell mapping further localised 15 candidates, including neurofilament light chain (NFL), to retinal neurons and glia. In the UK Biobank individuals, baseline plasma NFL distinguished those with diabetic retinopathy from control individuals (OR 1.98 [95% CI 1.61, 2.42]) and predicted incident diabetic retinopathy (HR 2.01 [95% CI 1.48, 2.73]) and vascular complications (microvascular, HR 2.28 [95% CI 1.94, 2.69]; macrovascular, HR 1.49 [95% CI 1.26, 1.77]) over a median follow-up of 12 years. Plasma NFL enhanced the predictability of a conventional risk factor model for diabetic retinopathy (net reclassification improvement [NRI] 0.194 [95% CI 0.042, 0.297]; integrated discrimination improvement [IDI] 0.015 [95% CI 0.003, 0.047]) and enabled risk stratification of vascular complications.Conclusions/interpretationNFL represents a pan-stage biomarker for diabetic retinopathy progression, detectable through minimally invasive plasma testing, and is associated with risks of diabetic vascular complications.Graphical Abstract</p>
19 Authors
- Jiahui Cao
- Fenghao Liu
- Huiqian Kong
- Chunran Lai
- Zijing Du
- Zhi Da Soh
- Ting Su
- Chenxiao Shen
- Qinyi Li
- Ying Fang
- Yijun Hu
- Xianwen Shang
- Xiaotao Shen
- Mingguang He
- Ching-Yu Cheng
- Zhuoting Zhu
- Meijuan Zhou
- Xiayin Zhang
- Honghua Yu
1 Application
| Application ID | Title |
|---|---|
| 86091 | Regulators of the association between ocular disorders and systemic diseases. |
Enabling scientific discoveries that improve human health